Can benztropine (Cogentin) cause myoclonus?

Can Cogentin Cause Myoclonus?

No, benztropine (Cogentin) does not typically cause myoclonus; rather, it is used to treat certain forms of myoclonus and extrapyramidal symptoms. In fact, the evidence shows benztropine has been successfully used as a treatment for anticholinergic-responsive myoclonus 1.

Evidence from Drug Labeling

The FDA-approved prescribing information for Cogentin does not list myoclonus as an adverse effect 2. The documented side effects include:

• Mental confusion and excitement (with large doses)
• Visual hallucinations (occasionally)
• Weakness and inability to move particular muscle groups
• Dysuria and urinary retention
• Anticholinergic effects (anhidrosis, tachycardia)

Clinical Context: Benztropine as Treatment

The pharmacological evidence actually demonstrates the opposite relationship:

Benztropine has been used successfully to treat myoclonus. A physiologic and pharmacologic study showed that two patients with essential myoclonus responded well to benztropine mesylate, with the mechanism involving direct antagonism of cholinergic hyperactivity 1. This suggests benztropine's anticholinergic properties can suppress, rather than cause, certain types of myoclonus.

Important Clinical Distinction

When myoclonus occurs in psychiatric patients taking benztropine, the actual culprit is typically:

1. The antipsychotic medication being treated (not the benztropine itself)
2. Withdrawal of benztropine - One case report documented acute-onset dyskinesia when benztropine was discontinued 3
3. Other concurrent medications - In one case, buspirone caused myoclonus that required benztropine (along with other agents) for treatment 4

Practical Implications

• If a patient on benztropine develops myoclonus, investigate other medications (particularly antipsychotics, SSRIs, opioids, or anesthetics) as the likely cause 5
• Do not discontinue benztropine abruptly, as withdrawal can paradoxically cause movement disorders 3
• Benztropine should be limited to 7 days for prophylactic use against antipsychotic-induced dystonia 6
• The guideline recommendation to avoid benztropine in Alzheimer's patients with extrapyramidal symptoms 7 relates to anticholinergic burden concerns, not myoclonus risk

Bottom line: Benztropine does not cause myoclonus and may actually treat certain forms of it through its anticholinergic mechanism.